Literature DB >> 12568486

Post-secretory fate of host defence components in mucus.

Matthias Salathe1, Rosanna Forteza, Gregory E Conner.   

Abstract

Airway mucus is a complex mixture of secretory products that provide a multifaceted defence against infection. Among many antimicrobial substances, mucus contains a peroxidase identical to milk lactoperoxidase (LPO) that is produced by goblet cells and submucosal glands. Airway secretions contain the substrates for LPO, namely thiocyanate and hydrogen peroxide, at concentrations sufficient for production of the biocidal compound hypothiocyanite, a fact confirmed by us in vitro. In vivo, inhibition of airway LPO in sheep significantly inhibits bacterial clearance, suggesting that the LPO system is a major contributor to host defences. Since secretory products including LPO are believed to be steadily removed by mucociliary clearance, their amount and availability on the surface is thought to be controlled solely by secretion. In contrast to this paradigm, new data suggest that LPO and other substances are retained at the ciliary border of the airway epithelium by binding to surface-associated hyaluronan, thereby providing an apical, fully active enzyme pool. Thus, hyaluronan, secreted from submucosal gland cells, plays a previously unrecognized pivotal role in mucosal host defence by retaining LPO and possibly other substances important for first line host defence at the apical surface 'ready for use' and protected from ciliary clearance.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12568486

Source DB:  PubMed          Journal:  Novartis Found Symp        ISSN: 1528-2511


  3 in total

Review 1.  Hyaluronan as an immune regulator in human diseases.

Authors:  Dianhua Jiang; Jiurong Liang; Paul W Noble
Journal:  Physiol Rev       Date:  2011-01       Impact factor: 37.312

2.  SPDEF is required for mouse pulmonary goblet cell differentiation and regulates a network of genes associated with mucus production.

Authors:  Gang Chen; Thomas R Korfhagen; Yan Xu; Joseph Kitzmiller; Susan E Wert; Yutaka Maeda; Alexander Gregorieff; Hans Clevers; Jeffrey A Whitsett
Journal:  J Clin Invest       Date:  2009-09-14       Impact factor: 14.808

Review 3.  Mucins in the mucosal barrier to infection.

Authors:  S K Linden; P Sutton; N G Karlsson; V Korolik; M A McGuckin
Journal:  Mucosal Immunol       Date:  2008-03-05       Impact factor: 7.313

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.